Interestingly, stimulation of signal transducer and activator of transcription 3 (STAT3) in astrocytes could reverse the mitochondrial impairment (Engin and Engin, 2021) and thus may be a novel candidate for the pharmacological treatment of PTSD. The gene discussed is STAT3; the disease is post-traumatic stress disorder.